The alternatives
REMEVi scores 83/100 (grade B, ranked #34) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to REMEVi's 83, and our REMEVi vs CoreAge Rx ruling sets the two out factor by factor.
Cheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.
Live Vital matches REMEVi at 83/100; the full Live Vital review has the pricing conditions and the caveats in detail.
Prints "No automatic renewals" on the plan card and names the pharmacy that dispenses — then advertises a price belonging to a different drug on a different term.
Rx.com scores 82/100 to REMEVi's 83; our full write-up on Rx.com has the pricing conditions and the caveats in detail.
A flat-fee compounded pioneer — simple model, but priced at the higher end now.
Henry Meds scores 84/100 to REMEVi's 83; the full Henry Meds review has the pricing conditions and the caveats in detail.
Will prescribe brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock access to its clinical team.
Synergy Rx scores 79/100 to REMEVi's 83; our Synergy Rx ruling in full has the pricing conditions and the caveats in detail.
Rock-bottom pricing on both molecules plus an oral route, nationwide — with the trade-off of no LegitScript listing.
Alan Meds scores 84/100 to REMEVi's 83; the full Alan Meds review has the pricing conditions and the caveats in detail.
A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.
Mochi Health scores 81/100 to REMEVi's 83; our full write-up on Mochi Health has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.